This content is from: Canada

Canada: Sands shift for pharma patents

Pharmaceutical patents are at the forefront of litigation in Canada. Andrew Bernstein and Grant Worden of Torys LLP in Toronto explain why, and consider proposed changes to rules on generic drugs

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial